课题基金 / 基金详情

Occludin-specific HCV cell entry mechanisms

Occludin-specific HCV cell entry mechanisms
Occludin 特异性 HCV 细胞进入机制
批准号：
8337067
负责人：
Matthew J Evans
金额：
$42.13万
依托单位：
ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI
依托单位国家：
美国
项目类别：
财政年份：
2011
资助国家：
美国
项目状态：
已结题
起止时间：
2011-09-30 至 2012-09-29
来源：
https://reporter.nih.gov/project-details/8337067
关键词：
Adverse effectsAmino AcidsAnimal ModelAntibody AffinityAntiviral AgentsAntiviral TherapyBiological ModelsCD81 geneCell physiologyCellsCharacteristicsClathrinDevelopmentEndocytosisEndosomesEpitopesEventGenerationsGeneticGenotypeGlycoproteinsGlycosaminoglycansGoalsHepatitis CHepatitis C virusHepatocyteHumanIndividualInterferonsKnowledgeLife Cycle StagesLightLiver diseasesLocationLow Density Lipoprotein ReceptorMammalian CellMapsMediatingMethodsMusMutagenesisMutationPan GenusPeptidesPlayProcessProteinsPublic HealthRegulationResearchResearch PersonnelRoleSR-BI receptorSurveysSystemTight JunctionsTissuesTropismUnited StatesVariantViralViral ProteinsVirionVirusVirus ReceptorsWorkbasecell typeclaudin-1 proteindrug developmentextracellularhuman PHEMX proteininhibitor/antagonistinnovationinsightinterestmutantnoveloccludinpathogenprotein protein interactionreceptorresearch and developmentresearch studyuptake

项目成果

Matthew J Evans的其他基金

相似基金

相关文献

期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Zika virus nonstructural protein 5 inhibition of interferon signaling
Deep mutational scanning of the Zika virus NS5 protein
Deep mutational scanning of the Zika virus NS5 protein
Interplay between flaviviruses and lipids
海外基金